National
Portugal: “The use of CBD for medicinal purposes requires authorization from INFARMED”
A recent decision of the Court of Justice of the European Union (CJEU) in relation to CBD predicted structural changes in European markets and in the legal status of this substance, by ruling that member states cannot ban the commercialization of CBD. What will the future of this industry in Europe look like? And in Portugal, does anything change or not?
The Cannareporter questioned the INFARMED — National Authority for Medicines and Health Products IP, on this decision by the CJEU and received the following response from the Medical Cannabis Cabinet. For now, and until there is a decision to reclassify cannabis and CBD in the 63rd Session of the CND — UN Convention on Drugs and Narcotics (United Nations) CBD remains subject to INFARMED authorization. But the National Medicines Authority admits changing the statute of CBD, if that is the result of the vote, and implementing the decision of the CND. The 63rd session of the CND takes place in Vienna, Austria, from 2 to 4 December 2020.
“The use of CBD or any substance derived from cannabis for medicinal purposes requires authorization from INFARMED. CBD's status as a controlled substance derives from the United Nations Conventions, ratified by the Portuguese State.
Effectively, any superior decision that changes the legal definitions of substances regulated by Infarmed, in our country, will have our best attention, in order to adjust our reality to the stipulated, thus complying with the legal obligations as we have done.
Additionally, as is public knowledge, several recommendations from the World Health Organization are under discussion in the United Nations Convention on Narcotic Drugs (CND), including the recommendation to exclude CBD from the scope of Table I of the Single Convention on United Nations of 1961. We are awaiting the decision of the CND on this and other WHO recommendations in this area, and depending on the decision that is taken, INFARMED will adopt the necessary steps with a view to implementing the decision”.
____________________________________________________________________________
Featured Photo: DR
____________________________________________________________________________________________________
[Disclaimer: Please note that this text was originally written in Portuguese and is translated into English and other languages using an automatic translator. Some words may differ from the original and typos or errors may occur in other languages.]____________________________________________________________________________________________________
What do you do with €3 a month? Become one of our Patrons! If you believe that independent cannabis journalism is necessary, subscribe to one of the levels of our Patreon account and you will have access to unique gifts and exclusive content. If there are many of us, we can make a difference with little!
With a degree in Journalism from the University of Coimbra, Laura Ramos has a postgraduate degree in Photography and has been a Journalist since 1998. Winner of the Business of Cannabis Awards in the category "Journalist of the Year 2024", Laura was a correspondent for Jornal de Notícias in Rome, Italy, and Press Officer in the Office of the Minister of Education of the 21st Portuguese Government. She has an international certification in Permaculture (PDC) and created the street-art photography archive “Say What? Lisbon” @saywhatlisbon. Co-founder and Editor of CannaReporter® and coordinator of PTMC - Portugal Medical Cannabis, Laura directed the documentary “Pacientes” and was part of the steering group of the first Postgraduate Course in GxP's for Medicinal Cannabis in Portugal, in partnership with the Military Laboratory and the Faculty of Pharmacy of the University of Lisbon.
Anar Artur: “Industrial hemp needs fresh and innovative solutions”
At 37, Anar Artur is one of the most committed voices in the promotion of hemp in Mongolia. With a career spanning...
The right to health and access to medicinal cannabis in Portugal: an unfulfilled constitutional promise
On May 31, 2025, the Cannabis March took place in Lisbon, where people from all over...
Berlin heats up for Cannabis Week with Mary Jane, Business of Cannabis B2B Sessions and CB Club x EmpowHer Meetup
The German capital will become the epicentre of the European cannabis scene next week, with a series of events...
CBD and CBDV demonstrate potent antifungal activity in peer-reviewed study
A study published in the journal PLOS Neglected Tropical Diseases confirms that cannabidiol (CBD) and cannabidivarin (CBDV) have potent...
Lighting the Way Forward: Why EMEA Growers Are Rethinking Retrofits
A new era of grow efficiency begins with smarter lighting decisions. As growers grow...
Systematic review addresses risks and benefits of medicinal cannabis in mental health
A systematic review entitled “The differential effects of medicinal cannabis on mental health” carried out by researchers from Erasmus University in...
Study reveals that Paracetamol can act through the endocannabinoid system
A study carried out by researchers from the University of Indiana, in the United States of America, and Leiden, in the...
European Drugs Report 2025 highlights rise in synthetic substances; agency director questions whether CBD could be considered a precursor
(updated on 6/6/2025 at 23:57 pm) The European Drugs Agency (EUDA) presented yesterday in Lisbon the 30th Drug Report...
Portugal: Infarmed changes requirements for import and export of medicinal cannabis. Companies concerned about speed of processes
Infarmed – National Authority for Medicines and Health Products IP has published new requirements for issuing certificates...
Czech Republic authorizes cultivation of three cannabis plants and therapeutic use of psilocybin
The Czech Republic's parliament approved on May 30 a comprehensive reform of the criminal code, which legalizes...
